# 

## 



|It's in the||Bag Cancer|Support<br>Ltd||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Reference||and administrative<br>details|||||||||
|Forthe|ear ended 31||December 2020||||||||
|Company||number|09646832||||||||
|Charity number|||1163735||||||||
|Registered||office and|Bristol Haematology||And|Oncology|Centre||||
|operational||address|Horfield Road||||||||
||||Bristol||||||||
||||BS28ED||||||||
|Trustees|||Trustees,<br>who are also directors||||under company||law, who served|during|
||||the year and up|to the date ofthis|||report were as follows:||||
||||Clayton<br>Bawden|||(resigned 13January|||2021)||
||||Jeremy Braybrooke||||||||
||||Richard Bullard||||||||
||||Stephen<br>Grey|||(appointed||2 December 2020)|||
||||Alison Harris|||(resigned 17April 2020)|||||
||||Sophie Mason|||(appointed||2 December 2020)|||
||||Michael Perry|||(appointed||22 January 2021)|||
||||Carolyn Sage|||(appointed||2 December 2020)|||
||||Nigel Williams||||||||
|Company||secretary|Susan Brand||||||||
|Bankers|||CAF Bank Ltd||||||||
||||25 Kings<br>Hill Avenue||||||||
||||Kings<br>Hill||||||||
||||West Mailing||||||||
||||Kent||||||||
||||ME194JQ||||||||
|Independent|||Godfrey Wilson|I imited|||||||
|examiners|||Chartered<br>accountants<br>and statutory<br>auditors||||||||
||||5th Floor Mariner|House|||||||
||||62 Prince Street||||||||
||||Bristol||||||||
||||BS14QD||||||||





## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 






## 

## 

## 





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

|Forthe<br>ear ended 31 December 2020||||
|---|---|---|---|
|||2020|2019|
|||Total|Total|
||Note|||
|Income from:||||
|Donations||49,689|78,893|
|Charitable<br>activities||||
|Celebrate|||5,902|
|Awareness||1,347|9,571|
|Other trading<br>activities|||4,187|
|Total income||51,036|98,553|
|Expenditure<br>on:||||
|Raising funds||1,415|19,346|
|Charitable<br>activities||||
|Celebrate|||14,553|
|Awareness||28,434|56,762|
|Support||10,362|16,037|
|Total expenditure||40,211|106,698|
|Net movement<br>in funds||10,825|(8,145)|
|Reconciliation<br>offunds:||||
|Total funds brought forward||57,849|65,994|
|Total funds carried forward||68,674|57,849|





## 

## 

## 

## 

|As at 31 Dec|embe|r 2020||||||
|---|---|---|---|---|---|---|---|
|||||||2020|2019|
|||||Note|||F|
|Fixed assets||||||||
|Tangible fixed assets||||10||863|947|
|Current assets||||||||
|Stock||||11|16,525||16,076|
|Debtors||||12|1,549||1,888|
|Cash at bank|and|in hand|||53,494||44,976|
||||||71,568||62,940|
|Liabilities<br>Creditors: amounts||falling due within|t year|13|~335y,||6,038|
|Net current|assets|||||67,811|56,902|
|Net assets||||||68,674|57,849|
|Funds||||14||||
|Unrestricted|funds|||||68,674|57,849|
|Total charity|funds|||||68,674|57,849|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 


## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

|||2020|2019|
|---|---|---|---|
|||Total|Total|
|Voluntary|donations*|45,887|70,475|
|Gift aid||3,802|8,418|
|Total income from donations||49,689|78,893|



## 

||||2020|2019|
|---|---|---|---|---|
||||Total|Total|
|||||F|
|Celebrate:|||||
|Celebration|event income|||5,902|
|Awareness:|||||
|Awareness|merchandise|sold|1,347|1,155|
|Testical Festival||||8,416|
||||1,347|9,571|



## 

|Income fro|m other trading<br>activities|||
|---|---|---|---|
|||2020|2019|
|||Total|Total|
||||E|
|Celebration|event sponsorship||4,000|
|Other income|||187|
|Total income from other trading activities|||4,187|






|0<br>Ql<br>(O0(<br>(D3<br>Ql<br>e0<br>8<br>(n<br>e|R<br>Ql<br>e<br>a0<br>C|g<br>O<br>(nC<br>DU<br>8.<br>8<br>(n|CO<br>C0'<br>0<br>Ql|& <br>OO <br>Oc <br>0 <br>PO|O<br> D<br> e0<br>QI<br> 0<br> 3|C <br>ee<br>e <br>D <br>(n <br>e|(e<br>Ql<br> 'c<br> Z<br>(D<br>I<br> 0<br> oO|Tl P<br>e a{n<br>SDC<br>Ql<br>H<br>Ql<br>I0<br>(nO<br>O<br>(n<br>(n<br>(n|Tl P<br>e a{n<br>SDC<br>Ql<br>H<br>Ql<br>I0<br>(nO<br>O<br>(n<br>(n<br>(n|Tl P<br>e a{n<br>SDC<br>Ql<br>H<br>Ql<br>I0<br>(nO<br>O<br>(n<br>(n<br>(n|e<br>0(n<br>g<br>(n <br>0<br>a ~<br>0<br>(ne<br>Ql D<br>9 C<br>(n' 0|e<br>0(n<br>g<br>(n <br>0<br>a ~<br>0<br>(ne<br>Ql D<br>9 C<br>(n' 0|QI<br> Q0<br>C|Q<br>Ql<br>(n<br>Ql<br>cr <br>e<br>0l|U<br>C<br>O<br> O.<br>Ql<br>QI<br>&<br>(D<br>(n|COP+<br>w<br>(n<br>e<br>O<br>QI<br>0c<br>(n<br>Ql<br>(n I<br>(D<br>(n (Oe(<br>(D<br>(n|COP+<br>w<br>(n<br>e<br>O<br>QI<br>0c<br>(n<br>Ql<br>(n I<br>(D<br>(n (Oe(<br>(D<br>(n|COP+<br>w<br>(n<br>e<br>O<br>QI<br>0c<br>(n<br>Ql<br>(n I<br>(D<br>(n (Oe(<br>(D<br>(n|||||0<br>Ql<br>e<br>De<br>O.<br>(D|Il<br>2<br>0I<br>ee<br>e<br>e<br>Og<br>n<br>cn<br>{D<br>o<br>Dl<br>ne<br>e|Il<br>2<br>0I<br>ee<br>e<br>e<br>Og<br>n<br>cn<br>{D<br>o<br>Dl<br>ne<br>e|g<br>Dl<br>CO<br>O<br>Ql<br>n<br>e<br>C|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|0I<br>CII|||||||||||e<br>0 <br>Ql<br>(O|Ql<br>(n<br> e||||||||||||hl<br>Cl||K|
||||||||||||(D||||||||||||||||
|hJ|||||||||||||||||||||||||||
|C3|||||||||||||||||||||||||||
||||||||||||||||||||||Ql||||||
||a<br>Ql|||I|I|I|(IJ<br>Ql<br>Ql|I|I|I|I|I|I|I|I|I|Ql<br>ol|I||O.<br>(n|rn<br>CO||||||
|||I|I|I|I|I|I|I|I|I|I|I|I|I|I|I|I|I|||||||||
|||||||||||||||||||||S|||||||
||II&<br>C»a|CI<br>(D|Vl|I|I|I|I|I|I||4l <br>O|ol<br> O<br> 0l||I|(»<br>(D|I|I|R|M|e<br> {n|||||||
|||||||||||||||||||||C{I|||||||
||CI<br>Ol|GJ<br>CD<br>(»<br>(In|0l<br>cD|I|I|I|I|I|I|I|I|I|I|Ql<br>(»<br>(D|I|Qlol<br>(2|I|||D'00|||||||
||||||||||||||||||||||0|01|||||
|||QI<br>4|a|M a cs)<br>M(p)4)<br>(» W Ql|||I|(D<br>cD a Ql<br>M-LN<br> a<br>C» Vl|||I|I|CD<br>(A||||||III|(n|e <br>0<br>(D|DO<br> o.|||||
|||||||||||||||||||||IID|||||||
||Cl<br>M||CI<br>hJ|IO a<br>4<br>Dn<br>{»a||CIn<br>Qn<br> vl|CIn<br>Cll <br>QI|CO~<br>CO a<br> M & <br> a c»||C»<br>4 <br> cll|lOOI <br>CIn O <br> CI Ol<br> c» w||~VI{»<br> ~ C»<br>Cll<br>CO &a <br> ~ co co|||Ql<br> OI <br> cI|CII<br> & <br> ol|Cll<br> C»<br> a||CI<br>0<br>Ql|||||||






|0<br>(D<br>e<br>IC<br>'Qe<br>C1<br>C|0<br>O<br>0<br>(hC000<br>00<br>(h<br>(n|CO<br>C<br>(D|000<br>(7I<br>0|(D<br>O<br>(D <br>O <br>O|Py<br>(D<br> e<br> ~<br> e<br>(he<br>rh|rn m<br>(<br>I<br>(D<br>(De<br>(D<br>DI 0e<br>zo<br>0<br>(h<br>n<br>(n<br>0<br>(n<br>(h|rn m<br>(<br>I<br>(D<br>(De<br>(D<br>DI 0e<br>zo<br>0<br>(h<br>n<br>(n<br>0<br>(n<br>(h|&~ol~<br>C1 (h<br>e (1<br>O<br>(h<br>x e<br>Gl<br>9 C<br>rh 0|&~ol~<br>C1 (h<br>e (1<br>O<br>(h<br>x e<br>Gl<br>9 C<br>rh 0|&~ol~<br>C1 (h<br>e (1<br>O<br>(h<br>x e<br>Gl<br>9 C<br>rh 0|&~ol~<br>C1 (h<br>e (1<br>O<br>(h<br>x e<br>Gl<br>9 C<br>rh 0|Q<br>(h<br>DI<br>~ <br>(1 <br>0<br>0<br>C<br>(D|C<br>O<br>H.<br>(h<br>e<br>w<br>DI<br> 0'g<br>0<br>(D<br>(h<br>(n<br>O<br>(D<br>CD|C<br>O<br>H.<br>(h<br>e<br>w<br>DI<br> 0'g<br>0<br>(D<br>(h<br>(n<br>O<br>(D<br>CD|'U <br>DI <br>e <br>g<br>0<br>'U<br>Dl<br>O<br>(h|'l3<br> C<br> 0<br>O.<br>QI<br>(De<br>(D<br>(n<br>(h|OMQ(<br>e c ~ e<br>eo f+<br>~.I "- "=<br>Dl( (n<br>&<br>rh<br>ee<br>e<br>(h|OMQ(<br>e c ~ e<br>eo f+<br>~.I "- "=<br>Dl( (n<br>&<br>rh<br>ee<br>e<br>(h|OMQ(<br>e c ~ e<br>eo f+<br>~.I "- "=<br>Dl( (n<br>&<br>rh<br>ee<br>e<br>(h|OMQ(<br>e c ~ e<br>eo f+<br>~.I "- "=<br>Dl( (n<br>&<br>rh<br>ee<br>e<br>(h|(De<br>g <br>~ <br>e|(D<br> e<br> e<br>Cn<br>cne(<br>(D<br>(h||||0<br>Dl<br>e<br>(D<br>C1<br>(D|0<br>e<br>a<br>e<br>col|z<br>0<br>ee<br>9<br>e<br>g<br>0<br>Q<br>e3<br>e|(n<br>g)<br>(D(0<br>0<br>e<br>'0<br>O|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||(h <br>0<br>DI(0e|e||||||||||||||||hl<br>CI<br>DhO|lD"|K|
||(IJ<br>(D<br>Ol<br>CD|Ol<br>OI<br>CI|I|I|I|tV<br>tA<br>CI<br>4)||I|I|I|I|I|I|I|I|I|I||CP <br>V <br>CD|(D<br>Cll<br> (D<br> (D|||C<br>(1<br>rh|(D<br>(n<br>Co||||||
||||||||||||||||||||||||Oe|||||||
||hJ||||||||||||||||||||||(T<br>U|||||||
||(D<br>(5<br>Q|Ol<br>V<br>CI|I|I|I|I|I|I|I|I|I|I|I|I|I|I|Ol<br>CI||||||rIl e|||||||
|QI<br>Ol<br>hl|||I|I|I|I|I|I|I|CD<br>(D|CI<br>CD|I|I|I|I|(D<br>hl<br>(Xl<br>l|I|I|I||G0<br>CI|4<br>O|(D<br>(D<br>e<br>lI) g|||||||
||||||||||||||||||||||||Ql|||||||
|Ol||hl||||||||||||||||Ol||||||||||||
|CI|hl<br>(0|V<br>Cll<br>CI|I|I|I|I|I|I|I|I|I|I|I|hl<br>Ol|Ol<br> CI|I||CD<br>IIl|||||0|||||||
|||||||||||||||||||||||||0|Ol|||||
||(D|ru|hl<br>(A ~ <br>CIP)(D|||<br>I|f <br> ~|(D 0)<br> RCD||I|I|g Cl<br>QllV|||||||||||0<br>0 <br>(n <br>(h|(D <br>PD<br> o<br> 0 <br> e|W0<br>(D<br> v<br> o.|||||
||||||||||||||||||||||||CI|||||||
|CD<br>CD(0<br>OI||CI<br>OI<br>OI<br>(O<br>Ol|~0 ~ Ill <br>hl(el~(44(OCOCD4(NOIR<br>CD O 04 O 0<br>CO ~ (O<br>CO 4<br>CO <br>O<br>Ch (O Q &4 (O V & CII Q|||||||||||V<br> IIl <br> (I|Ol<br>0|PDCII4 <br>CO V Eh <br> V 0 IIh|||4(hill<br> V (O O<br> (O (O &|||O|(0|||||||





## 

## 

## 

||||||||2020f|2019|
|---|---|---|---|---|---|---|---|---|
|Grants|to|individuals|-|18|grants|(2019:24)|5,819|7,228|



## 

||||||||2020|2019|
|---|---|---|---|---|---|---|---|---|
||||||||K||
|Depreciation|||||||434|303|
|Trustees'|remuneration||||||Nil|Nil|
|Trustees'|reimbursed||expenses||||335|1,139|
|Independent||examiner's||remuneration:|||||
||~|Independent||examination|(including|VAT)|1,278|1,260|



## 

## 



## 

## 

|10.Tangible fixe|d asse|ts||||
|---|---|---|---|---|---|
||||||Equipment|
||||||F|
|Cost||||||
|At 1 January|2020||||1,383|
|Additions<br>in year|||||350|
|At 31 December 2020|||||1,733|
|Depreciation||||||
|At 1 January|2020||||436|
|Charge for the year|||||434|
|At 31 December 2020|||||870|
|Net book value||||||
|At 31 December 2020|||||863|
|At 31 December 2019|||||947|
|11.Stock||||||
|||||2020|2019|
|||||E:||
|Merchandise|for resale|||16,525|16,076|
|12.Debtors||||||
|||||2020|2019|
|||||E'.||
|P repayments||||711|1,274|
|Other debtors||||838|614|
|||||1,549|1,888|
|13.Creditors: amounts||falling due within|1year|||
|||||2020|2019|
|||||f.||
|Accruals||||3,757|5,898|
|Deferred income|||||140|
|||||3,757|6,038|





## 

## 

|Movements<br>in funds||||
|---|---|---|---|
|||2020|2019|
|At 1 January 2020||57,849|65,994|
|Income||51,036|98,553|
|Expenditure||~40,211|~106,696|
|At 31 December 2020||57,849|57,849|
|All fund were unrestricted|in both periods.|||



##